Contact us to learn more about

our Premium Content: News alerts, weekly reports and conference planners

BIOMARKER:

PGR positive

Contact us to learn more about our Premium Content:

News alerts, weekly reports and conference planners

Entrez ID:

Related biomarkers:

‹

PIK3CA mutation + HR positive (16)

ESR1 mutation + HR positive (6)

ESR1 wild-type + HR positive (4)

BRCA1 mutation + HR positive (3)

BRCA2 mutation + HR positive (3)

FGFR1 amplification + HR positive (3)

HR positive + BRCA2 mutation (3)

HR-positive + PIK3CA wild-type (3)

PIK3CA exon 20 mutation + HR positive (3)

AKT1 E17K + HR positive (2)

AKT1 mutation + HR positive (2)

ER positive + TP53 mutation (2)

HR negative + BRCA1 mutation (2)

HR negative + BRCA2 mutation (2)

HR positive + BRCA1 mutation (2)

HR positive + MYC amplification (2)

HR positive + TP53 mutation (2)

BRCA1 mutation + HER-2 negative + ER positive + PGR positive (1)

BRCA2 mutation + ER positive + PGR positive (1)

CCND1 mutation + HR positive (1)

CCND2 mutation + HR positive (1)

CDK4 mutation + HR positive (1)

CDKN1B mutation + HR positive (1)

ER negative + HER-2 positive + PGR positive + PIK3CA mutation (1)

ER positive + MLH1 1835del3 + MSI-H/dMMR + TMB-H (1)

ESR1 mutation + PIK3CA mutation + HR positive (1)

HER-2 amplification + ER positive + PGR negative (1)

HR negative + EGFR amplification (1)

HR positive + APOBEC signature (1)

HR positive + AURKA amplification (1)

HR positive + AURKA mutation (1)

HR positive + BRAF V600E (1)

HR positive + BRCA1 mutation + PALB2 mutation (1)

HR positive + BRCA2 mutation + PALB2 mutation (1)

HR positive + BRIP1 amplification (1)

HR positive + CCND1 amplification (1)

HR positive + HER-2 amplification (1)

HR positive + HER-2 mutation (1)

HR positive + MYC mutation (1)

HR positive + PIK3CA exon 10 mutation (1)

HR positive + PTEN deletion (1)

HR positive + RAD51C amplification (1)

HR positive + RB1 mutation (1)

HR positive + TMB-H (1)

HR positive + TMB-L (1)

High HDAC6 score + HR positive (1)

KRAS mutation + CDK9 overexpression + HR positive (1)

KRAS mutation + HR positive (1)

MTOR mutation + HR positive (1)

PIK3CA E542K + HR positive (1)

PIK3CA amplification + PIK3CA mutation + HR positive (1)

PIK3CA exon 7 mutation + HR positive (1)

PIK3CA exon 9 mutation + HR positive (1)

PIK3CA mutation + HR positive + HER-2 negative (1)

PTEN mutation + HR positive (1)

HR positive + HER-2 negative + TMB-L (0)

PIK3CA mutation + ER negative + PGR positive (0)

PIK3CA mutation + HR positive (16)

ESR1 mutation + HR positive (6)

ESR1 wild-type + HR positive (4)

BRCA1 mutation + HR positive (3)

BRCA2 mutation + HR positive (3)

FGFR1 amplification + HR positive (3)

HR positive + BRCA2 mutation (3)

HR-positive + PIK3CA wild-type (3)

PIK3CA exon 20 mutation + HR positive (3)

AKT1 E17K + HR positive (2)

AKT1 mutation + HR positive (2)

ER positive + TP53 mutation (2)

HR negative + BRCA1 mutation (2)

HR negative + BRCA2 mutation (2)

HR positive + BRCA1 mutation (2)

HR positive + MYC amplification (2)

HR positive + TP53 mutation (2)

BRCA1 mutation + HER-2 negative + ER positive + PGR positive (1)

BRCA2 mutation + ER positive + PGR positive (1)

CCND1 mutation + HR positive (1)

CCND2 mutation + HR positive (1)

CDK4 mutation + HR positive (1)

CDKN1B mutation + HR positive (1)

ER negative + HER-2 positive + PGR positive + PIK3CA mutation (1)

ER positive + MLH1 1835del3 + MSI-H/dMMR + TMB-H (1)

ESR1 mutation + PIK3CA mutation + HR positive (1)

HER-2 amplification + ER positive + PGR negative (1)

HR negative + EGFR amplification (1)

HR positive + APOBEC signature (1)

HR positive + AURKA amplification (1)

HR positive + AURKA mutation (1)

HR positive + BRAF V600E (1)

HR positive + BRCA1 mutation + PALB2 mutation (1)

HR positive + BRCA2 mutation + PALB2 mutation (1)

HR positive + BRIP1 amplification (1)

HR positive + CCND1 amplification (1)

HR positive + HER-2 amplification (1)

HR positive + HER-2 mutation (1)

HR positive + MYC mutation (1)

HR positive + PIK3CA exon 10 mutation (1)

HR positive + PTEN deletion (1)

HR positive + RAD51C amplification (1)

HR positive + RB1 mutation (1)

HR positive + TMB-H (1)

HR positive + TMB-L (1)

High HDAC6 score + HR positive (1)

KRAS mutation + CDK9 overexpression + HR positive (1)

KRAS mutation + HR positive (1)

MTOR mutation + HR positive (1)

PIK3CA E542K + HR positive (1)

PIK3CA amplification + PIK3CA mutation + HR positive (1)

PIK3CA exon 7 mutation + HR positive (1)

PIK3CA exon 9 mutation + HR positive (1)

PIK3CA mutation + HR positive + HER-2 negative (1)

PTEN mutation + HR positive (1)

HR positive + HER-2 negative + TMB-L (0)

PIK3CA mutation + ER negative + PGR positive (0)

›

PGR positive	Uterine Corpus Leiomyosarcoma	PGR positive	Uterine Corpus Leiomyosarcoma	Aromatase inhibitor Sensitive: A2 - Guideline Aromatase inhibitor Sensitive : A2	Aromatase inhibitor Sensitive: A2 - Guideline Aromatase inhibitor Sensitive : A2
PGR positive	HER2 Negative Breast Cancer	PGR positive	HER2 Negative Breast Cancer	anastrozole Sensitive: A2 - Guideline anastrozole Sensitive : A2	anastrozole Sensitive: A2 - Guideline anastrozole Sensitive : A2
PGR positive	HER2 Negative Breast Cancer	PGR positive	HER2 Negative Breast Cancer	letrozole Sensitive: A2 - Guideline letrozole Sensitive : A2	letrozole Sensitive: A2 - Guideline letrozole Sensitive : A2
PGR positive	Uterine Corpus Leiomyosarcoma	PGR positive	Uterine Corpus Leiomyosarcoma	medroxyprogesterone Sensitive: A2 - Guideline medroxyprogesterone Sensitive : A2	medroxyprogesterone Sensitive: A2 - Guideline medroxyprogesterone Sensitive : A2
PGR positive	Uterine Corpus Leiomyosarcoma	PGR positive	Uterine Corpus Leiomyosarcoma	megestrol Sensitive: A2 - Guideline megestrol Sensitive : A2	megestrol Sensitive: A2 - Guideline megestrol Sensitive : A2
PGR positive	HER2 Positive Breast Cancer	PGR positive	HER2 Positive Breast Cancer	trastuzumab Sensitive: B - Late Trials trastuzumab Sensitive : B	trastuzumab Sensitive: B - Late Trials trastuzumab Sensitive : B
PGR positive	Uterine Cancer	PGR positive	Uterine Cancer	anastrozole Sensitive: C2 – Inclusion Criteria anastrozole Sensitive : C2	anastrozole Sensitive: C2 – Inclusion Criteria anastrozole Sensitive : C2
PGR positive	HER2 Positive Breast Cancer	PGR positive	HER2 Positive Breast Cancer	Sensitive: C3 – Early Trials Sensitive : C3	Sensitive: C3 – Early Trials Sensitive : C3
PGR positive	Uterine Corpus Leiomyosarcoma	PGR positive	Uterine Corpus Leiomyosarcoma	anastrozole Sensitive: C3 – Early Trials anastrozole Sensitive : C3	anastrozole Sensitive: C3 – Early Trials anastrozole Sensitive : C3
PGR positive	HER2 Negative Breast Cancer	PGR positive	HER2 Negative Breast Cancer	Aromatase inhibitor Sensitive: C3 – Early Trials Aromatase inhibitor Sensitive : C3	Aromatase inhibitor Sensitive: C3 – Early Trials Aromatase inhibitor Sensitive : C3